| Product Code: ETC7656974 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Neurometabolic Disorders Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Neurometabolic Disorders Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Neurometabolic Disorders Market - Industry Life Cycle |
3.4 Israel Neurometabolic Disorders Market - Porter's Five Forces |
3.5 Israel Neurometabolic Disorders Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Neurometabolic Disorders Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Israel Neurometabolic Disorders Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis of neurometabolic disorders in Israel |
4.2.2 Advancements in medical research and technology for better treatment options |
4.2.3 Growing prevalence of neurometabolic disorders in the population |
4.3 Market Restraints |
4.3.1 High costs associated with diagnosis and treatment of neurometabolic disorders |
4.3.2 Limited access to specialized healthcare services in certain regions of Israel |
4.3.3 Regulatory challenges and approvals for new treatments |
5 Israel Neurometabolic Disorders Market Trends |
6 Israel Neurometabolic Disorders Market, By Types |
6.1 Israel Neurometabolic Disorders Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Neurometabolic Disorders Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Israel Neurometabolic Disorders Market Revenues & Volume, By Gauchers Disease, 2021- 2031F |
6.1.4 Israel Neurometabolic Disorders Market Revenues & Volume, By Fabry Disease, 2021- 2031F |
6.1.5 Israel Neurometabolic Disorders Market Revenues & Volume, By Pompe Disease, 2021- 2031F |
6.1.6 Israel Neurometabolic Disorders Market Revenues & Volume, By Mucopolysaccharidosis VI, 2021- 2031F |
6.1.7 Israel Neurometabolic Disorders Market Revenues & Volume, By Other, 2021- 2031F |
6.2 Israel Neurometabolic Disorders Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Neurometabolic Disorders Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 Israel Neurometabolic Disorders Market Revenues & Volume, By Parenteral, 2021- 2031F |
7 Israel Neurometabolic Disorders Market Import-Export Trade Statistics |
7.1 Israel Neurometabolic Disorders Market Export to Major Countries |
7.2 Israel Neurometabolic Disorders Market Imports from Major Countries |
8 Israel Neurometabolic Disorders Market Key Performance Indicators |
8.1 Number of research studies and clinical trials conducted on neurometabolic disorders in Israel |
8.2 Percentage increase in early detection rates of neurometabolic disorders |
8.3 Adoption rate of new treatment modalities and therapies |
8.4 Patient satisfaction levels with access to healthcare services for neurometabolic disorders |
8.5 Rate of collaboration between healthcare providers and research institutions in developing innovative solutions for neurometabolic disorders |
9 Israel Neurometabolic Disorders Market - Opportunity Assessment |
9.1 Israel Neurometabolic Disorders Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Neurometabolic Disorders Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Israel Neurometabolic Disorders Market - Competitive Landscape |
10.1 Israel Neurometabolic Disorders Market Revenue Share, By Companies, 2024 |
10.2 Israel Neurometabolic Disorders Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here